Blueberry Therapeutics have unique nanopolymer drug delivery technology which opens up huge opportunities to rapidly develop new medicines and helps us find ways to treat infection & inflammation.
Blueberry is committed to the development of innovative therapies to treat diseases where infection and inflammation are major factors.
We use cutting-edge nano polymer drug delivery technology to exploit both small molecule and biologic approaches to developing treatments.
Blueberry Therapeutics CSO David Cook presents at the first Royal Society Creating Connections conference, Research, industry and infrastructure in the North West, at [...]
John Ridden, CEO of Blueberry Therapeutics, recently presented at the UK-China Life Science Event run by the DIT (Department [...]